维普中文期刊产品整合服务
17篇 您的检索式:作者名="Samonakis DN"
    题名 作者 年代 出处 被引量
1Infection,coagulation,and variceal bleeding in cirrhosis显示文摘Thalh eimer U Triantos CK Samonakis DN 2005Gut2005,54,4:1
2Burroughs Inmunosuppression and HCV recurrence after liver transplantation显示文摘Samonakis DN Germani G Burroughs AK 0,,:1
3Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis显示文摘Samonakis DN Cholongitas E Thalheimer U 2007Liver Transpl2007,13,9:1
4Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma : A message not well taken 显示文摘Samonakis DN Nots G Christodoutakis N 2008Dig Dis Sci2008,1,3:1
5Infection, coagulation, and variceal bleeding in cirrhosis显示文摘Thalheimer U Triantos CK Samonakis DN 2005Gut2005,54,4:1
6Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Moschandreas J Arnaoutis T 2002Oncol Rep2002,9,:1
7Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Moschandreas J Amaoutis T 2002Oncol Rep2002,9,4:1
8Management of portal hypertension 显示文摘DN Samonakis C K Triantos U Thalheimer 2004Postgrad Med J2004,80,949:1
9Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Moschandreas J Arnaoutis T 2002Oncol Rep2002,9,4:1
10Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Moschandreas J Arnaoutis T 2002Oncol Rep2002,9,4:1
11Treatment of hepatocellular carcinoma with long acting somatostatin analogues 显示文摘Samonakis DN Moschandreas J Amaotis T 2002Oncol Rep2002,9,4:1
12Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken 显示文摘Samonakis DN Notas G Christodoulakis N 2008Dig Dis Sci2008,53,9:1
13Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients显示文摘Thalheimer U Leandro G Samonakis DN 2005Dig Liver Dis2005,37,8:1
14Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Moschandreas J Arnaoutis T 2002Oncol Rep2002,9,4:1
15Treatment of hepatocellular carcinoma with long acting somatostatin analogues显示文摘Samonakis DN Joanna M Theodora A 2002Oncology Rep2002,9,4:1
16Hypercoagulable states in patients with hepatocellular carcinoma显示文摘Samonakis DN Koutroubakis IE Sfiridaki A 2004Digestive Disases and Sciences2004,49,5:1
17肝移植术后的免疫抑制治疗与丙型肝炎复发显示文摘丙型肝炎肝硬化是目前肝移植术的最常见适应证。术后丙型肝炎的复发很常见,并且可对患者以及移植物的存活产生重大影响。免疫抑制是加速丙型肝炎复发以及缩短复发性丙型肝炎自然病程的一个主要机制,也是一个研究并不够深入的领域。对于HCV移植患者来说,免疫抑制治疗要达到一种很好的平衡状态为最佳,即抑制机体免疫力以对抗移植物排斥反应和维持机体最佳抗病毒应答反应的平衡。基于这个原则,越来越多的证据提供了许多数据来支持某些免疫抑制治疗策略。Samonakis DN 王玉洁 谢雯 2012肝脏2012,17,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费